← Back to Search

Mindfulness Based Walking Therapy (MBWT) for Parkinson's Disease (MMR34 Trial)

N/A
Waitlist Available
Led By Kerri Rawson, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

MMR34 Trial Summary

This trial will study if a mindfulness intervention can help people with Parkinson disease who have freezing of gait, a severe motor disturbance.

Eligible Conditions
  • Parkinson's Disease
  • Freezing of Gait

MMR34 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence: Number of Hours Participants Practice Mindfulness at Home
Attendance of Participants: Number of Participants at Each Session
Recruitment of Sample: Number of Participants Recruited
+1 more

MMR34 Trial Design

1Treatment groups
Experimental Treatment
Group I: Mindfulness Based Walking Therapy (MBWT)Experimental Treatment1 Intervention
Participants will participate in MBWT.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Based Walking Therapy (MBWT)
2022
N/A
~10

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,935 Previous Clinical Trials
2,299,864 Total Patients Enrolled
Kerri Rawson, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
24 Total Patients Enrolled
Gammon Earhart, PT, PhDPrincipal InvestigatorWashington University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the ceiling of participants for this trial?

"Affirmative. The clinicaltrials.gov database reveals that this trial, which was first published on March 4th 2022, is actively collecting applicants. A total of 24 subjects need to be enrolled from one specific medical facility."

Answered by AI

Is this clinical examination currently welcoming participants?

"According to clinicaltrials.gov, applications are now being accepted for this trial which was first introduced on March 4th 2022 and revised most recently on April 21st 2022."

Answered by AI
~3 spots leftby Apr 2025